Skip to content

Clinical trials

Phase 3 Emphysema trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Emphysema Phase: Phase 3 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20043
20054
20061
20071
20082
20094
20114
20122
20134
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Withdrawn4
Unknown status3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Aeris Therapeutics3
Sumitomo Pharma America, Inc.3
Emphasys Medical2
GlaxoSmithKline2
National Heart, Lung, and Blood Institute (NHLBI)2
Temple University2
Alung Technologies1
Asan Medical Center1
Broncus Technologies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Emphysema30
Pulmonary Disease, Chronic Obstructive30
Bronchitis, Chronic13
Bronchitis3
Lung Diseases3
Lung Diseases, Obstructive3
Pulmonary Emphysema3
Bronchiolitis Obliterans Syndrome2
Respiratory Tract Diseases2
Asthma1

Trials

Showing 26 to 30 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.